Back to Search
Start Over
Targeting of VPS18 by the lysosomotropic agent RDN reverses TFE3-mediated drug resistance.
- Source :
-
Signal transduction and targeted therapy [Signal Transduct Target Ther] 2021 Jun 07; Vol. 6 (1), pp. 224. Date of Electronic Publication: 2021 Jun 07. - Publication Year :
- 2021
- Subjects :
- Basic Helix-Loop-Helix Leucine Zipper Transcription Factors genetics
Drug Resistance, Neoplasm genetics
Humans
Neoplasm Proteins genetics
Neoplasms drug therapy
Neoplasms genetics
Neoplasms pathology
PC-3 Cells
Vesicular Transport Proteins genetics
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors metabolism
Drug Resistance, Neoplasm drug effects
Neoplasm Proteins metabolism
Neoplasms metabolism
Phenyl Ethers chemistry
Phenyl Ethers pharmacology
Stilbenes chemistry
Stilbenes pharmacology
Vesicular Transport Proteins metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 2059-3635
- Volume :
- 6
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Signal transduction and targeted therapy
- Publication Type :
- Report
- Accession number :
- 34099617
- Full Text :
- https://doi.org/10.1038/s41392-021-00547-x